Montag & Associates’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-600	Closed	-$48.7K	–	1031
2025 Q1	$48.7K	Hold	600	–	–	﹤0.01%	624
2024 Q4	$54K	Sell	600 -40,809	-99%	-$3.68M	﹤0.01%	596
2024 Q3	$4.09M	Buy	41,409 +3,584	+9%	+$354K	0.19%	112
2024 Q2	$3.51M	Buy	37,825 +323	+0.9%	+$29.9K	0.18%	122
2024 Q1	$3.56M	Buy	37,502 +34,652	+1,216%	+$3.29M	0.18%	123
2023 Q4	$254K	Hold	2,850	–	–	0.01%	374
2023 Q3	$208K	Hold	2,850	–	–	0.01%	375
2023 Q2	$237K	Sell	2,850 -835	-23%	-$69.5K	0.01%	376
2023 Q1	$281K	Hold	3,685	–	–	0.02%	342
2022 Q4	$306K	Sell	3,685 -1,411	-28%	-$117K	0.02%	317
2022 Q3	$404K	Buy	5,096 +435	+9%	+$34.5K	0.03%	278
2022 Q2	$346K	Hold	4,661	–	–	0.02%	306
2022 Q1	$419K	Hold	4,661	–	–	0.02%	311
2021 Q4	$522K	Buy	4,661 +406	+10%	+$45.5K	0.03%	293
2021 Q3	$535K	Hold	4,255	–	–	0.03%	285
2021 Q2	$576K	Hold	4,255	–	–	0.03%	282
2021 Q1	$577K	Buy	4,255 +5	+0.1%	+$678	0.03%	280
2020 Q4	$598K	Hold	4,250	–	–	0.04%	258
2020 Q3	$474K	Hold	4,250	–	–	0.04%	233
2020 Q2	$476K	Hold	4,250	–	–	0.04%	223
2020 Q1	$329K	Buy	4,250 +1,250	+42%	+$96.8K	0.03%	240
2019 Q4	$285K	Hold	3,000	–	–	0.02%	266
2019 Q3	$229K	Hold	3,000	–	–	0.02%	279
2019 Q2	$263K	Hold	3,000	–	–	0.02%	274
2019 Q1	$272K	Hold	3,000	–	–	0.03%	270
2018 Q4	$215K	Sell	3,000 -2,750	-48%	-$197K	0.02%	272
2018 Q3	$551K	Buy	+5,750	New	+$551K	0.05%	233